“…This allowed for the multicenter analysis of disparate databases. This consisted of the following information: person, drug exposure, drug era, condition occurrence, condition error, observation period, observation, procedure occurrence, visit occurrence, death, drug cost, procedure cost, location, provider, organization, care site, payment plan period, and cohort ( 26 ). The analysis period and total number of patients were 2003 to 2020 and 880,392 from MJ, 2006 to 2017 and 822,183 from KH, 2006 to 2019 and 2,363,386 from CHA, and 2011 to 2018 and 1,753,001 from PS.…”